SCHEMBL19945973

SCHEMBL19945973

CCc1coc(C(CC(C(N)=O)c2ccccc2)c2ccc([N+](=O)[O-])cc2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.40
MEN1 O00255 3/20 0.40
NPC1 O15118 2/20 0.39
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
MAPT P10636 2/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 3/20 0.35
NR1I2 O75469 1/20 0.35
NR3C1 P04150 1/20 0.35
ADRA1A P35348 1/20 0.35
KCNH2 Q12809 1/20 0.35
CYP2C9 P11712 1/20 0.35
GAA P10253 1/20 0.35
AKR1C3 P42330 1/20 0.34
AKR1C2 P52895 1/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15990731 0.81 ALDH1A1 (0.38) NPC1CNR1CNR2MAPTHTT
SCHEMBL19945972 0.78 CCR3 (0.40) KMT2AMEN1NPC1MAPTHTT
SCHEMBL1287146 0.77 OPRM1 (0.52) KMT2AMEN1CNR1CNR2HTT
SCHEMBL6462715 0.70 TSHR (0.49) KMT2AMEN1NPC1MAPTNPSR1
SCHEMBL500100 0.69 SMN1; SMN2 (0.39) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL17429759 0.69 SMN1; SMN2 (0.39) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL468070 0.69 KMT2A (0.58) KMT2AMEN1NPC1HTTALDH1A1
SCHEMBL683522 0.69 KMT2A (0.58) KMT2AMEN1NPC1HTTALDH1A1
Hydrochloric Acid SCHEMBL1647739 0.69 TSHR (0.47) KMT2AMEN1NPC1MAPTNPSR1
SCHEMBL6625969 0.68 EPHX1 (0.69) KMT2AMEN1NPC1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3293182-A1 HUMAN PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE Aerpio Therapeutics, Inc. (US) 2018-03-14 EP disclosed